Potentiometric and Visual Titrimetric Methods for Analysis of Captopril and Its Pharmaceutical Forms
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Analytical Letters
- Vol. 16 (1) , 45-55
- https://doi.org/10.1080/00032718308064460
Abstract
Captopril, a new anihypertensive agent, has been assayed in authenitic as well as in tablet (Capoten((R))Manufacture: Squibb and Sons, Inc., Princeton, N.J., U.S.A. dosage forms by applying potentiometric visual, argentometric and oxidometric methods of idoine and cupric ion. Each method of assay involves the determination of captopril in a given weight of sample. Six samples were run for each method and the average percentages of recovery of captopril from its tablets were computed. For the potentiometric and visual silver methods the average percentages of recovery are 103.3 ± 1.2 and 102.3 ± 1.0 respectively. For the oxidometic methods of iodine and cupric ion, the average percentages of recovery are 103.8 ± 1.5 and 104.2 ± 1.4 respectively.Keywords
This publication has 13 references indexed in Scilit:
- High-Performance Liquid Chromatographic Analysis of Captopril in PlasmaJournal of Pharmaceutical Sciences, 1981
- Determination of captopril in blood and urine by high-performance liquid chromatography.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981
- Gas chromatography/selected ion monitoring mass spectrometric determination of captopril in human bloodAnalytical Chemistry, 1980
- Determinatin of captopril in biological fluids by gas-liquid chromatographyJournal of Chromatography A, 1980
- Thin-Layer Radiochromatographic Determination of Captopril (SQ 14,225) and its Disulfide Dimer Metabolite in BloodJournal of Liquid Chromatography, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Angiotensin Converting-Enzyme Inhibitor in Refractory HypertensionNew England Journal of Medicine, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acidsBiochemistry, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977